CSF data were available in 31 (71%) AID patients w/o MS (NLRP3 variants: n = 15; 88%, MEFV variants: n = 10; 53%, and TNFRSF1A variants: n = 6; 75%). Here, NLRP3 is linked to myeloid sarcoma.